349 related articles for article (PubMed ID: 22610061)
1. Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series.
Sasaki S; Miyakoshi N; Hongo M; Kasukawa Y; Shimada Y
J Bone Miner Metab; 2012 Sep; 30(5):561-7. PubMed ID: 22610061
[TBL] [Abstract][Full Text] [Related]
2. Oral bisphosphonates and risk of subtrochanteric or diaphyseal femur fractures in a population-based cohort.
Kim SY; Schneeweiss S; Katz JN; Levin R; Solomon DH
J Bone Miner Res; 2011 May; 26(5):993-1001. PubMed ID: 21542002
[TBL] [Abstract][Full Text] [Related]
3. Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric/diaphyseal fractures? The study of osteoporotic fractures.
Napoli N; Jin J; Peters K; Wustrack R; Burch S; Chau A; Cauley J; Ensrud K; Kelly M; Black DM
J Clin Endocrinol Metab; 2012 Jul; 97(7):2414-22. PubMed ID: 22547423
[TBL] [Abstract][Full Text] [Related]
4. Healing delayed but generally reliable after bisphosphonate-associated complete femur fractures treated with IM nails.
Egol KA; Park JH; Rosenberg ZS; Peck V; Tejwani NC
Clin Orthop Relat Res; 2014 Sep; 472(9):2728-34. PubMed ID: 23604648
[TBL] [Abstract][Full Text] [Related]
5. Atypical femoral fractures related to bisphosphonate use: A comprehensive review of 19 patients.
Şahin K; Ergin ON; Bayram S; Akgül T
Ulus Travma Acil Cerrahi Derg; 2019 Nov; 25(6):603-610. PubMed ID: 31701502
[TBL] [Abstract][Full Text] [Related]
6. Sequential subtrochanteric femoral fracture after atypical diaphyseal fracture in a long-term bisphosphonate user: a case report.
Park KT; Lee KB
Acta Chir Orthop Traumatol Cech; 2015; 82(2):157-60. PubMed ID: 26317188
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated with Increased Healing Time in Complete Femoral Fractures After Long-Term Bisphosphonate Therapy.
Lim HS; Kim CK; Park YS; Moon YW; Lim SJ; Kim SM
J Bone Joint Surg Am; 2016 Dec; 98(23):1978-1987. PubMed ID: 27926679
[TBL] [Abstract][Full Text] [Related]
8. Bone Formation Parameters of the Biopsied Ilium Differ between Subtrochanteric and Diaphyseal Atypical Femoral Fractures in Bisphosphonate-Treated Patients.
Kondo N; Fukuhara T; Watanabe Y; Miyasaka D; Yamamoto N; Sato H; Wada Y; Nakatsue T; Fujisawa J; Sakuma M; Imai N; Yoda T; Narita I; Endo N
Tohoku J Exp Med; 2017 Dec; 243(4):247-254. PubMed ID: 29212985
[TBL] [Abstract][Full Text] [Related]
9. The outcome of surgically treated femur fractures associated with long-term bisphosphonate use.
Weil YA; Rivkin G; Safran O; Liebergall M; Foldes AJ
J Trauma; 2011 Jul; 71(1):186-90. PubMed ID: 21610533
[TBL] [Abstract][Full Text] [Related]
10. Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.
Shane E; Burr D; Ebeling PR; Abrahamsen B; Adler RA; Brown TD; Cheung AM; Cosman F; Curtis JR; Dell R; Dempster D; Einhorn TA; Genant HK; Geusens P; Klaushofer K; Koval K; Lane JM; McKiernan F; McKinney R; Ng A; Nieves J; O'Keefe R; Papapoulos S; Sen HT; van der Meulen MC; Weinstein RS; Whyte M;
J Bone Miner Res; 2010 Nov; 25(11):2267-94. PubMed ID: 20842676
[TBL] [Abstract][Full Text] [Related]
11. Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium.
Lee JK
Int J Rheum Dis; 2009 Jul; 12(2):149-54. PubMed ID: 20374333
[TBL] [Abstract][Full Text] [Related]
12. Bilateral simultaneous femoral diaphyseal fractures in a patient with long-term ibandronate use.
Patel VC; Lazzarini AM
Orthopedics; 2010 Oct; 33(10):775. PubMed ID: 20954650
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonate-associated femur fractures have high complication rates with operative fixation.
Prasarn ML; Ahn J; Helfet DL; Lane JM; Lorich DG
Clin Orthop Relat Res; 2012 Aug; 470(8):2295-301. PubMed ID: 22669553
[TBL] [Abstract][Full Text] [Related]
14. Critical differences between subtrochanteric and diaphyseal atypical femoral fractures: analyses of 51 cases at a single institution in Korean population.
Cho YJ; Kang KC; Chun YS; Rhyu KH; Kim SJ; Jang TS
Arch Osteoporos; 2018 May; 13(1):53. PubMed ID: 29725835
[TBL] [Abstract][Full Text] [Related]
15. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM
Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707
[TBL] [Abstract][Full Text] [Related]
16. Atypical diaphyseal femoral fractures: Considerations on surgical technique.
Spinelli MS; Marini E; Daolio PA; Piccioli A
Injury; 2019 Jul; 50 Suppl 2():S65-S69. PubMed ID: 30782394
[TBL] [Abstract][Full Text] [Related]
17. Retrospective review of patients with atypical bisphosphonate related proximal femoral fractures.
Phillips HK; Harrison SJ; Akrawi H; Sidhom SA
Injury; 2017 Jun; 48(6):1159-1164. PubMed ID: 28410753
[TBL] [Abstract][Full Text] [Related]
18. Treatment of femoral fracture nonunion after long-term bisphosphonate use.
Grady MK; Watson JT; Cannada LK
Orthopedics; 2012 Jun; 35(6):e991-5. PubMed ID: 22691683
[TBL] [Abstract][Full Text] [Related]
19. Atypical femur fractures: a review.
Bronson WH; Kaye ID; Egol KA
Curr Osteoporos Rep; 2014 Dec; 12(4):446-53. PubMed ID: 25287009
[TBL] [Abstract][Full Text] [Related]
20. Diaphyseal femur fractures associated with bisphosphonate use.
Graham J; Irgit K; Smith WR; Bowen TR
Acta Orthop Traumatol Turc; 2013; 47(4):255-60. PubMed ID: 23999513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
